This article has been updated to include Enzo's R&D and SG&A costs for the quarter.

NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market Monday that its second quarter revenues rose 7 percent year over year.

For the three months ended Jan. 31, the company reported revenues of $26.3 million, up from $24.6 million in Q2 2015.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.